Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03037307 · ClinicalTrials.gov registry record · NA

A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive

A NA study, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
44
Enrollment target

NCT03037307 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03037307, a NA study, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

The objective of this study will be to compare bite force (BF) measurements over a 12-hour period of a currently marketed denture adhesive cream based on carbomer technology (test), with a positive control and a negative/no treatment control.

Interventions

  • OTHER Negative Control
  • OTHER Test Product
  • OTHER Positive Contol

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2017-02-13
Est. Completion 2017-05-04
Phase NA

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT03037307

The ClinicalTrials.gov registry entry for NCT03037307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Negative Control is the first listed.

NCT03037307 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03037307 about?

NCT03037307 is a clinical study titled "A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive". The objective of this study will be to compare bite force (BF) measurements over a 12-hour period of a currently marketed denture adhesive cream based on carbomer technology (test), with a positive control and a negative/no treatment control.

What is the current status of trial NCT03037307?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2017-02-13. Estimated completion is 2017-05-04.

What interventions are being tested in trial NCT03037307?

The interventions under investigation include: Negative Control (OTHER), Test Product (OTHER), Positive Contol (OTHER).

Who is sponsoring clinical trial NCT03037307?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.